|
Prognostic stromal and immune response expression patterns in early-stage colorectal cancer predicted by genes intrinsically expressed by tumor epithelial cells. |
| |
|
Consulting or Advisory Role - Bayer |
| |
|
No Relationships to Disclose |
| |
|
|
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Merck Serono; Regeneron |
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Merck Serono; Regeneron; Roche/Genentech |
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi |
Research Funding - Bayer (Inst); Merck Serono (Inst); Regeneron (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi |
| |
|
|
Stock and Other Ownership Interests - Genentech |